Antimicrobial Activity of Daptomycin Tested Against Staphylococcus aureus and Enterococcus spp. Clinical Strains Isolated in European Medical Centers (2002-2005)
Antimicrobial Activity of Daptomycin Tested Against Staphylococcus aureus and Enterococcus spp. Clinical Strains Isolated in European Medical Centers (2002-2005), Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Tigecycline Activity Tested Against Gram-positive Cocci and Enterobacteriaceae Collected in Europe, North America and Latin America
Tigecycline Activity Tested Against Gram-positive Cocci and Enterobacteriaceae Collected in Europe, North America and Latin America, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Activity of Meclocycline Sulfosalicylate Tested Against Oral Pathogens
Activity of Meclocycline Sulfosalicylate Tested Against Oral Pathogens, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Regional Differences in Activity of Tigecycline Tested Against Acinetobacter spp.: Results from a Global Surveillance Programme (2003-2005)
Regional Differences in Activity of Tigecycline Tested Against Acinetobacter spp.: Results from a Global Surveillance Programme (2003-2005), Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Tigecycline Activity Against Staphylococcus aureus, Including Vancomycin-Intermediate and -Resistant Isolates
Tigecycline Activity Against Staphylococcus aureus, Including Vancomycin-Intermediate and -Resistant Isolates, Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bloodstream Infection Isolates Collected in France, Germany, and Italy
Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bloodstream Infection Isolates Collected in France, Germany, and Italy, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal
Report from the 2005 Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS)
Report from the 2005 Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS), Lead author: Jones RN, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Analysis of the Influence of Surfactant (Tween-80) Concentrations on Susceptibility Testing Results for the Polymyxins by Broth Microdilution Methods
Analysis of the Influence of Surfactant (Tween-80) Concentrations on Susceptibility Testing Results for the Polymyxins by Broth Microdilution Methods, Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Carbapenem -Resistant Serratia marcescens Producing SME-2, a Carbapenem-Hydrolyzing Class A β-Lactamase, Isolated in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program (2004)
Carbapenem -Resistant Serratia marcescens Producing SME-2, a Carbapenem-Hydrolyzing Class A β-Lactamase, Isolated in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program (2004), Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Re-Emergence of Linezolid Resistance in Clonally Distinct Staphylococcus aureus Strains Causing Pulmonary Infection in a Cystic Fibrosis Patient: Initial Case Studies from Latin America
Re-Emergence of Linezolid Resistance in Clonally Distinct Staphylococcus aureus Strains Causing Pulmonary Infection in a Cystic Fibrosis Patient: Initial Case Studies from Latin America, Lead author: Deshpande LM, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Report from the 2005 MYSTIC Surveillance Program (USA): Influence of Antimicrobial Resistant Clusters on Overall Prevalence Patterns
Report from the 2005 MYSTIC Surveillance Program (USA): Influence of Antimicrobial Resistant Clusters on Overall Prevalence Patterns, Lead author: Rhomberg PR, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
A Multi-Site Study of Gemifloxacin MIC Results on the Sensititre® 18-24 Hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method
A Multi-Site Study of Gemifloxacin MIC Results on the Sensititre® 18-24 Hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method, Lead author: Miskov AM, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
A Multi-Site Study of Ertapenem MIC Results on the Sensititre® 18-24 hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method
A Multi-Site Study of Ertapenem MIC Results on the Sensititre® 18-24 hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method, Lead author: Killian SB, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Multicenter Studies to Establish Tigecycline Disk Diffusion Susceptibility Breakpoints when Testing Acinetobacter spp
Multicenter Studies to Establish Tigecycline Disk Diffusion Susceptibility Breakpoints when Testing Acinetobacter spp, Lead author: Jones RN, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Assessment of Colistin and Polymyxin B Antimicrobial Susceptibility Testing Methods Against Non-Fermentative Gram-Negative Bacilli (NFGNB)
Assessment of Colistin and Polymyxin B Antimicrobial Susceptibility Testing Methods Against Non-Fermentative Gram-Negative Bacilli (NFGNB), Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Disk Diffusion Susceptibility Testing of Campylobacter spp.: Use in Detection of Resistance to Macrolides and Fluoroquinolones
Disk Diffusion Susceptibility Testing of Campylobacter spp.: Use in Detection of Resistance to Macrolides and Fluoroquinolones, Lead author: Fritsche TR, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida
Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected from European Medical Centres in 2005: Results of the Daptomycin Surveillance Programme
Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected from European Medical Centres in 2005: Results of the Daptomycin Surveillance Programme, Lead author: Streit J, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Antimicrobial Activity of Cefepime Tested Against Ceftazidime-Resistant Gram-Negative Clinical Strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2004
Antimicrobial Activity of Cefepime Tested Against Ceftazidime-Resistant Gram-Negative Clinical Strains from North American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2004, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Isolates Causing Bloodstream Infections in European Medical Centers: Report from 9 years of the SENTRY Antimicrobial Surveillance Program in Europe (1997-2005)
Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Isolates Causing Bloodstream Infections in European Medical Centers: Report from 9 years of the SENTRY Antimicrobial Surveillance Program in Europe (1997-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Antimicrobial Potency and Spectrum of Activity for Meropenem: Report from the USA MYSTIC Programme (2005)
Antimicrobial Potency and Spectrum of Activity for Meropenem: Report from the USA MYSTIC Programme (2005), Lead author: Rhomberg PR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
In Vitro Efficacy of Tigecycline Tested Against Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Including Analyses of 72 Co-Resistance Patterns
In Vitro Efficacy of Tigecycline Tested Against Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Including Analyses of 72 Co-Resistance Patterns, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
In Vitro Activity of Tigecycline Tested Against an International Collection of Minocycline-Resistant Bacterial Pathogens (2000-2004)
In Vitro Activity of Tigecycline Tested Against an International Collection of Minocycline-Resistant Bacterial Pathogens (2000-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Antimicrobial Activity of Tigecycline, a Glycylcycline, Tested Against Carbapenemase-Producing Enterobactereaceae
Antimicrobial Activity of Tigecycline, a Glycylcycline, Tested Against Carbapenemase-Producing Enterobactereaceae, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Activity of Tigecycline Tested Against an International Collection (2000-2004) of AmpC-Producing Enterobacteriaceae
Activity of Tigecycline Tested Against an International Collection (2000-2004) of AmpC-Producing Enterobacteriaceae, Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Five Year Evaluation of Clonal Dissemination and Expansion of VIM-1 Producing Enterobacteriaceae in Greece: A Report from the SENTRY Antimicrobial Surveillance Program (2001-2005)
Five Year Evaluation of Clonal Dissemination and Expansion of VIM-1 Producing Enterobacteriaceae in Greece: A Report from the SENTRY Antimicrobial Surveillance Program (2001-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
VIM-1 producing Enterobacter cloacae strains from Madrid, Spain: Report from the SENTRY Antimicrobial Surveillance Program 2005
VIM-1 producing Enterobacter cloacae strains from Madrid, Spain: Report from the SENTRY Antimicrobial Surveillance Program 2005, Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Comparison of Dalbavancin MIC Values Tested Against Gram-Positive Organisms Using Etest (AB BIODISK) and Reference Dilution Methods
Comparison of Dalbavancin MIC Values Tested Against Gram-Positive Organisms Using Etest (AB BIODISK) and Reference Dilution Methods, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Re-evaluation of the Role of Broad-Spectrum Cephalosporins against Staphylococci Applying Contemporary In Vitro Results and Pharmacokinetic-Pharmacodynamic (PK-PD) Principals
Re-evaluation of the Role of Broad-Spectrum Cephalosporins against Staphylococci Applying Contemporary In Vitro Results and Pharmacokinetic-Pharmacodynamic (PK-PD) Principals, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Potency of Garenoxacin Tested Against an International Collection of Staphylococcus aureus Isolates, Including Oxacillin- and Ciprofloxacin-Resistant Subsets (2004-2005)
Potency of Garenoxacin Tested Against an International Collection of Staphylococcus aureus Isolates, Including Oxacillin- and Ciprofloxacin-Resistant Subsets (2004-2005), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Garenoxacin Activity Tested Against S. pneumoniae, H. influenzae and M. catarrhalis with Elevated or Resistant Fluoroquinolone MIC Values
Garenoxacin Activity Tested Against S. pneumoniae, H. influenzae and M. catarrhalis with Elevated or Resistant Fluoroquinolone MIC Values, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Evaluation of Garenoxacin (GRN) Activity Tested Against All Patterns of Multi-Resistant (MDR) S. pneumoniae: Multi-Center Studies of Nearly 15,000 Isolates
Evaluation of Garenoxacin (GRN) Activity Tested Against All Patterns of Multi-Resistant (MDR) S. pneumoniae: Multi-Center Studies of Nearly 15,000 Isolates, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Garenoxacin Activity and Potency against S. pneumoniae and H. influenzae Respiratory Tract Isolates (2004-2005): Report from a Worldwide Surveillance Network
Garenoxacin Activity and Potency against S. pneumoniae and H. influenzae Respiratory Tract Isolates (2004-2005): Report from a Worldwide Surveillance Network, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
In Vitro Activity of Garenoxacin Tested Against Ciprofloxacin-Susceptible and -Resistant Enterobacteriaceae and Acinetobacter spp. Strains Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (2004-2005)
In Vitro Activity of Garenoxacin Tested Against Ciprofloxacin-Susceptible and -Resistant Enterobacteriaceae and Acinetobacter spp. Strains Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (2004-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Contemporary Prevalence of BRO β-Lactamases in M. catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (USA; 1997-2004)
Contemporary Prevalence of BRO β-Lactamases in M. catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (USA; 1997-2004), Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Doripenem (DOR) European Surveillance: Antimicrobial Activity Against 6,480 Contemporary Pathogens (2004)
Doripenem (DOR) European Surveillance: Antimicrobial Activity Against 6,480 Contemporary Pathogens (2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Analysis of Skin and Soft Tissue Infections in European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program (1998-2005).
Analysis of Skin and Soft Tissue Infections in European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program (1998-2005)., Lead author: Moet G, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Changing Patterns of Antimicrobial Resistances Among Bacterial Isolates Recovered from European Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Programme (1998-2004)
Changing Patterns of Antimicrobial Resistances Among Bacterial Isolates Recovered from European Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Programme (1998-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Cefepime Tested Alone and in Combination with Clavulanic Acid, Gentamicin, and Tobramycin Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus
Cefepime Tested Alone and in Combination with Clavulanic Acid, Gentamicin, and Tobramycin Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus, Lead author: Rybak M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Metallo-Beta-Lactamase Gene blaSPM-1: Evaluation of its vicinities in unrelated P. aeruginosa strains isolated from distinct Brazilian Hospitals
Metallo-Beta-Lactamase Gene blaSPM-1: Evaluation of its vicinities in unrelated P. aeruginosa strains isolated from distinct Brazilian Hospitals, Lead author: Castanheira M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Discrepancy in the metallo-beta-lactamase phenotypic tests results associated with diversity in the promoter region of class 1 integrons
Discrepancy in the metallo-beta-lactamase phenotypic tests results associated with diversity in the promoter region of class 1 integrons, Lead author: Castanheira M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa with doripenem plus an aminoglycoside.
Delayed resistance selection for doripenem when passaging Pseudomonas aeruginosa with doripenem plus an aminoglycoside. by Huynh HK, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 55 (3): 241-243
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly?
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly? by Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2006; 55 (4): 351-356
Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. by Gales AC, Sader HS, Andrade SS, Lutz L, Machado A and Barth AL published in Int. J. Antimicrob. Agents 2006; 27 (4): 300-302
Clonal occurrences of multidrug-resistant Gram-negative bacilli: Report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
Clonal occurrences of multidrug-resistant Gram-negative bacilli: Report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004). by Rhomberg PR, Fritsche TR, Sader HS, Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (4): 249-257
International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003).
International surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003). by Messer SA, Jones RN and Fritsche TR published in J. Clin. Microbiol. 2006; 44 (5): 1782-1787
Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin.
Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin. by Fernandez-Cuenca F, Martinez-Martinez L, Amblar G, Biedenbach DJ, Jones RN and Pascual A published in Clin. Microbiol. Infect. 2006; 12 (2): 197-198
Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004).
Global assessment of the antimicrobial activity of polymyxin B against 54,731 clinical isolates of Gram-negative bacilli: Report from the SENTRY Antimicrobial Surveillance Programme (2001-2004). by Gales AC, Jones RN and Sader HS published in Clin. Microbiol. Infect. 2006; 12 (4): 315-321
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents.
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents. by Sader HS, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2006; 44 (3): 1101-1104
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program.
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: Report from the SENTRY Antimicrobial Surveillance Program. by Bhavnani SM, Ambrose PG, Craig WA, Dudley MN and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (3): 231-236
Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Emergence and epidemiology for fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004). by Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 53 (3): 157-164
